IPATASERTIB for Her2 negative breast cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where IPATASERTIB was used for Her2 negative breast cancer.
Most Reported Side Effects for IPATASERTIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 17 | 13.6% | 4 | 11 |
| Pyrexia | 11 | 8.8% | 0 | 10 |
| Fatigue | 10 | 8.0% | 1 | 5 |
| Hyperglycaemia | 9 | 7.2% | 3 | 5 |
| Rash | 8 | 6.4% | 2 | 4 |
| Nausea | 7 | 5.6% | 2 | 2 |
| Vomiting | 7 | 5.6% | 2 | 3 |
| Acute kidney injury | 6 | 4.8% | 0 | 6 |
| Pneumonitis | 6 | 4.8% | 1 | 2 |
| Rash maculo-papular | 6 | 4.8% | 0 | 4 |
| Anaemia | 5 | 4.0% | 2 | 2 |
| Dehydration | 5 | 4.0% | 0 | 5 |
| Drug ineffective | 5 | 4.0% | 0 | 1 |
Other Indications for IPATASERTIB
Triple negative breast cancer (26)
Breast cancer (17)
Hormone-refractory prostate cancer (14)
Prostate cancer (11)
Breast cancer metastatic (9)
Prostate cancer metastatic (8)
Neoplasm (7)
Other Drugs Used for Her2 negative breast cancer
LETROZOLE (250)
RIBOCICLIB (247)
FAM-TRASTUZUMAB DERUXTECAN-NXKI (220)
PACLITAXEL (146)
FULVESTRANT (137)
ANASTROZOLE (97)
PALBOCICLIB (95)
GOSERELIN (67)
CYCLOPHOSPHAMIDE (65)
BEVACIZUMAB (63)